Treatment algorithm for newly diagnosed T2DM

HbA1c <6.5% AND FPG <6.0 mmol/L
•	Consider metformin monotherapy (only one form of medication)
•	if post prandial is > 11.0 mmol/L and/or metformin not tolerated, use:
    o	Meglitinide
    o	AGI (α-glucosidase inhibitor)
    o	DPP4-i (DPP4-inhibitors)

HbA1c 6.5-7.4% OR FPG 6.0-7.9 mmol/L
•	Mono or dual therapy with
    o	Metformin OR
    o	SU (Sulphonylureas)
    o	DPP4-i
    o	SGLT2-i (SGLT2-inhibitors)

HbA1c 7.5-8.4% OR FPG 8.0-9.9 mmol/L
•	Dual combination therapy with any combination of:
    o	Metformin 
    o	SU 
    o	Meglitinide 
    o	AGI 
    o	TZD (Thiazolidinedione)
    o	DPP4-i 
    o	GLP1-RA 
    o	SGLT2-i 
    o	Insulin

HbA1c 8.5-10.0% OR FPG 10.0-13.0 mmol/L
•	Triple combination therapy with any combination of:
    o	Metformin 
    o	SU 
    o	Meglitinide 
    o	AGI 
    o	TZD 
    o	DPP4-i 
    o	GLP1-RA
    o	SGLT2-i 
    o	Insulin

HbA1c >10.0% OR FPG >13.0 mmol/L
•	Basal/premixed insulin therapy + Combination therapy
            or
•	Intensive insulin therapy + OGLD

Treatment recommendations: Clinic follow-up
When HbA1c above individualised target with lifestyle modification + existing therapy
0.5%-1% above target :
•	Add 1 additional GLD from different class 
•	OR Intensification of insulin (if already on insulin)

1%-2% above target :
•	Consider 2 GLDs from different classes 
•	OR Intensification of insulin (if already on insulin)

>2% above target :
•	Initiation of insulin/GLP1-RA 
•	OR Intensification of insulin

Hypoglycaemia
•   impaired fasting glucose of 3.9 millimoles per liter (mmol/L), or below should serve as an alert for hypoglycemia
•   happens when blood glucose level is abnormally low

Hyperglcaemia
•   impaired fasting glucose of 10 - 11.1 millimoles per liter (mmol/L) will show symptoms of hyperglycaemia
•   happens when blood glucose level is high for a prolonged time